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Abstract
Functional and molecular changes associated with pathophysiological conditions are relatively easily detected
based on tissue samples collected from patients. Population specific cellular responses to disease might remain
undiscovered in samples taken from organs formed by a multitude of cell types. This is particularly apparent in the
human cerebral cortex composed of a yet undefined number of neuron types with a potentially different
involvement in disease processes. We combined cellular electrophysiology, anatomy and single cell digital PCR in
human neurons identified in situ for the first time to assess mRNA expression and corresponding functional
changes in response to edema and increased intracranial pressure. In single pyramidal cells, mRNA copy numbers
of AQP1, AQP3, HMOX1, KCNN4, SCN3B and SOD2 increased, while CACNA1B, CRH decreased in edema. In addition,
single pyramidal cells increased the copy number of AQP1, HTR5A and KCNS1 mRNAs in response to increased
intracranial pressure. In contrast to pyramidal cells, AQP1, HMOX1and KCNN4 remained unchanged in single cell
digital PCR performed on fast spiking cells in edema. Corroborating single cell digital PCR results, pharmacological
and immunohistochemical results also suggested the presence of KCNN4 encoding the α-subunit of KCa3.1
channels in edema on pyramidal cells, but not on interneurons. We measured the frequency of spontaneous EPSPs
on pyramidal cells in both pathophysiological conditions and on fast spiking interneurons in edema and found a
significant decrease in each case, which was accompanied by an increase in input resistances on both cell types
and by a drop in dendritic spine density on pyramidal cells consistent with a loss of excitatory synapses. Our results
identify anatomical and/or physiological changes in human pyramidal and fast spiking cells in edema and increased
intracranial pressure revealing cell type specific quantitative changes in gene expression. Some of the edema/
increased intracranial pressure modulated and single human pyramidal cell verified gene products identified here
might be considered as novel pharmacological targets in cell type specific neuroprotection.
Introduction
Brain edema and an increase in intracranial pressure (ICP)
might result from a number of insults including traumatic
brain injury, cerebral ischemia, hypoxia, infection, brain
tumors, and neuroinflammation [35]. The localization and
extent of brain damage correlates with the neurological
outcome, but permanent deterioration and death are also
causally linked to edema or infarct of the perilesional tis-
sue. The mainstream treatment for edema and increased
ICP has been unchanged during the last 35–40 years
(cerebrospinal fluid drainage, sedation, hyperventilation,
osmotherapy, steroids, barbiturate and decompressive cra-
niectomy as an ultimum refugium) [36, 44] and no target
designed pharmacological treatment specifically lowering
brain edema is available to patients [36, 44].
Advances in unbiased large scale molecular approaches
are proven to be successful in pinpointing individual or
multiple genes associated with a disease [1]. Omics based
assessment of human pathological conditions is usually
based on tissue samples containing a mixture of cell types.
Blood samples are relatively easily sorted into different cell
classes prior to molecular characterization, but similarly
automatized methods are not readily available for biopsies
taken from solid tissues [8, 28]. The cerebral cortex,
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composed of several distinct classes of neurons, glial cells
and cell types forming the vasculature, is particularly chal-
lenging from this respect [22, 46] and pioneering laser-
capture microdissection studies confirm cell type specific
expression patterns in disease [33]. Previous work showed
that neuron classes recorded in acute brain slices made
from biopsies of the cerebral cortex can be classified based
on their electrophysiological features [21, 24, 34, 43]. Such
recordings allow intracellular labeling and anatomical ana-
lysis of the recorded cells further refining the identifica-
tion of cell types. Moreover, whole cell patch clamp
recordings provide an opportunity for harvesting cyto-
plasm from electrophysiologically and morphologically
identified neurons [25, 41]. Quantification of mRNA with
single molecule precision from the cytoplasm collected
from individual neurons [13, 23] could provide cell type
specific information in addition to tissue level changes,
and, in turn, electrophysiological recordings can further
validate the function of therapeutically relevant genes in
identified neurons [23]. We present a workflow for de-
tecting disease related mRNA expression changes in bi-
opsies of the cerebral cortex which is capable of
validating the alterations predicted at the tissue level
with the precision of individual mRNA molecules in
single neurons combined with functional validation in
identified cells targeted in situ.
Materials and methods
Patients
We analysed neocortical tissue surgically removed from
patients (n = 37, n = 22 female and n = 15 male, aged 49 ±
14 years) in a course of two years as part of the treatment
protocol for aneurysms, brain tumors and/or increased
intracranial pressure. Tissue blocks were removed from
prefrontal (n = 22), temporal (n = 8) and parietal (n = 7)
areas. Patients were grouped according to the presence of
edema based on MRI scans showing hypointense signal in
T1 weighted sequences and hyperintense signal in T2
weighted sequences [35] and according to measurements
of ICP using Codman Microsensor™ ventricular and/or
parenchymal kit [5]. Patient group 1 (Control, n = 11, n =
5 female and n = 6 male, aged 46 ± 15 years) had no de-
tectable edema or increase in ICP. These patients were
diagnosed with unruptured aneurisms (n = 2) and be-
nign (n = 56) or malignant (n = 3) tumors (WHO grade
II) detected serendipitously at early stages. Patient
group 2 (Edema, n = 18, n = 12 female and n = 6 male,
aged 52 ± 11 years) showed edema on MRI scans and
0–14 Hgmm ICP. These patients were diagnosed with
primary benign (n = 3) or malign brain tumors (n = 12),
tumor metastases (n = 2) or abscess (n = 1). Patient
group 3 (Pressure, n = 10, n = 7 female and n = 3 male,
aged 42 ± 16 years) showed no edema on MRI scans
and had 21–43 Hgmm ICP. These patients suffered
from hydrocephalus caused by benign (n = 4) or malign
(n = 4) brain tumors, by a colloid cyst (n = 1) or by
Arnold-Chiari syndrome (n = 1).
Electrophysiology
All procedures were performed according to the Declar-
ation of Helsinki with the approval of the University of
Szeged Ethical Committee. Human slices were derived
from material which had to be removed according to
treatment protocols from prefrontal regions (gyrus fron-
talis superior and medialis of either hemispheres and
right gyrus frontalis inferior, the left gyrus frontalis infer-
ior was avoided in order to keep Broca’s area intact),
from temporal regions of both hemispheres (gyrus tem-
poralis superior, medialis and inferior) and from parietal
regions with written informed consent patients prior to
surgery over the last three years. Patients having a rec-
ord of epileptic seizures and with drugs related to epi-
lepsy were excluded from the study. Anesthesia was
induced with intravenous midazolam and fentanyl
(0.03 mg/kg, 1–2 μg/kg respectively). A bolus dose of
propofol (1–2 mg/kg) was administered intravenously.
To facilitate endotracheal intubation, the patient re-
ceived 0.5 mg/kg rocuronium. After 120 s the trachea
was intubated and the patient was ventilated with a
mixture of O2 and N2O at a ratio of 1:2. Anesthesia
was maintained with sevoflurane at minimum alveolar
concentration volume of 1.2–1.5. Blocks of tissue were
immersed into ice cold solution containing (in mM)
130 NaCl, 3.5 KCl, 1 NaH2PO4, 24 NaHCO3, 1 CaCl2,
3 MgSO4, 10 d (+)-glucose, saturated with 95 % O2
and 5 % CO2 in the operating theatre, sliced at a thick-
ness of 350 μm with a vibrating blade microtome
(Microm HM 650 V) and were incubated at room
temperature for 1 h in the same solution. The solution
used during recordings differed only in that it con-
tained 2 mM CaCl2 and 1.5 mM MgSO4. Recordings
were obtained at ~36 °C from up to four concomi-
tantly recorded cells visualized in layer 2/3 by infrared
differential interference contrast videomicroscopy at
depths 60–130 μm from the surface of the slice. Mi-
cropipettes (5–7 MΩ) were filled with an intracellular
solution containing 126 mM K-gluconate, 4 mM KCl,
10 mM HEPES, 10 mM creatine phosphate, 8 mM bio-
cytin; pH 7.25; 300 mOsm supplemented with RNase
Inhibitor (1U/μl, Life Technologies) to prevent any
RNA degradation. Access resistance was monitored
with −10 mV voltage steps in between experimental
epochs and data collection was terminated if access re-
sistance exceeded 30 MΩ. Signals were filtered at
8 kHz, digitized at 16 kHz and analyzed with PULSE
software. Membrane properties of human neurons or
polysynaptic events did not show significant changes
for up to 20 h after slicing, but recordings included in
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the analysis were arbitrarily terminated 15 h after slice
preparation. Traces shown are single sweeps (firing
patterns) or averages or of 50–100 consecutive epi-
sodes (pharmacology). The effects during drug appli-
cation were tested following 5 min wash-in periods.
Visualization of biocytin and microscopy was per-
formed as described earlier [24].
Single cell reverse transcription and digital PCR
At the end of electrophysiological recordings, the intra-
cellular content was aspirated into the recording pipettes
by application of a gentle negative pressure while main-
taining the tight seal. Pipettes were then delicately re-
moved to allow outside-out patch formation, and the
content of the pipettes (~1.5 μl) was expelled into a low-
adsorbtion test tube (Axygen) containing 0.5 μl SingleCell-
ProtectTM (Avidin Ltd. Szeged, Hungary) solution in
order to prevent nucleic acid degradation and to be com-
patible with direct reverse transcription reaction. Samples
were snap-frozen in liquid nitrogen and stored or immedi-
ately used for reverse transcription. The reverse transcrip-
tion of the harvested cytoplasm was carried out in two
steps. The first step was done for 5 min at 65 °C in a total
reaction volume of 5 μl containing 2 μl intracellular solu-
tion and SingleCellProtectTM mix with the cytoplasmic
contents of the neuron, 0.3 μl TaqMan Assays, 0.3 μl
10 mM dNTPs, 1 μl 5× first-strand buffer, 0.3 μl 0.1 mol/
L DTT, 0.3 μl RNase inhibitor (Life Technologies) and 100
U of reverse transcriptase (Superscript III, Invitrogen).
The second step of the reaction was carried out at 55 °C
for 1 h and then the reaction was stopped by heating at
75 °C for 15 min. The reverse transcription reaction mix
was stored at −20 °C until PCR amplification.
For digital PCR analysis, half of the reverse transcrip-
tion reaction mixture (2.5 μl), 2 μl TaqMan Assays (Life
Technologies), 10 μl OpenArray Digital PCR Master
Mix (Life Technologies) and nuclease free water (5.5 μl)
were mixed in a total volume of 20 μl. The mixture was
evenly distributed on an OpenArray plate. RT mixes
were loaded into 4 wells of a 384-well plate from which
the OpenArray autoloader transferred the cDNA master
mix by capillary action into 256 nanocapillary holes (4
subarrays) on an OpenArray plate. Processing of the
OpenArray slide, cycling in the OpenArray NT cycler
and data analysis were done as previously described [13].
For our dPCR protocol amplification, reactions with CT
confidence values below 100 as well as reactions having
CT values less than 23 or greater than 33 were consid-
ered primer dimers or background signals, respectively,
and excluded from the data set.
RNA preparation, amplification and labeling
Total RNA was purified from each sample using an
RNA purification kit (Macherey Nagel, Düren, Germany)
according to the manufacturer’s instructions. At a final
concentration of 0.8 U/μl, an RNase inhibitor (Fermentas,
Lithuania) was added to the samples. RNA quantity was
determined using Agilent Bioanalyzer 2100 NanoDrop
3.1.0. RNA samples were stored at −80 °C before used. An
aliquot of the total RNA (1 μg) was amplified with the
AminoAllyl MessageAmpTM II aRNA Amplification Kit
(Ambion, USA) according to the manufacturer’s instruc-
tions. Six microgram aminoallyl-modified amplified RNA
(aaRNA) was labeled with Cy3 dye according to the man-
ufacturer’s instructions (Ambion, USA) then purified. The
dye incorporation rate and the labeled aRNA concentra-
tion were detected using NanoDrop 3.1.0. The incorpor-
ation rate of the samples was 30–60 dye molecules per
1000 nucleotides.
Microarray hybridization, raw data extraction and analysis
The human oligonucleotide microarray (Whole Human
Genome Microarray, 4 × 44 K, G4112F, Design ID 014850)
from Agilent Technologies Inc. (Santa Clara, CA, USA)
was used to determine gene expression changes. 825 ng of
Cy3 labeled aaRNA, 11 μl 10× Blocking Agent and 2.2 μl
25× Fragmentation Buffer were mixed together in a final
volume of 55 μl and incubated at 60 °C for 30 min then
55 μl 2× GEx Hybridization Buffer were added to each
sample to stop the fragmentation reaction. All these steps
were done using Gene Expression Hybridization Kit of
Agilent Technologies according to the manufacturer’s in-
structions. 100 μl of these mixes were used to fill the 4-
plex backing slides and the microarray was placed onto it.
This “hybridization sandwich” was assembled in an Agilent
microarray hybridization chambers. The chambers were
then loaded into a hybridization rotator rack (~5 rpm) and
incubated at 65 °C for 17 h. After hybridization the slides
were washed in Wash buffer 1 from Agilent Technologies
at room temperature for 1 min than in Wash buffer 2 at
37 °C for another 1 min before scanning. Each array was
scanned at 543 nm (for Cy3 labeling) in Agilent Scan-
ner (G2505B) using the extended dynamic range func-
tion with 5 μm resolution. Output image analysis and
feature extraction was done using Feature Extraction
9.5.1 software using the single-color gene expression
protocol (GE1_1100_Jul11).
All the raw data extracted by Feature Extraction soft-
ware was statistically analyzed by GeneSpringGX 13.0
software from Agilent Technologies. Percentile Shift
Normalization method was applied to globally normalize
all the spot intensities. All the ratios were calculated
from the average signal intensities in each groups (con-
trol n = 9, odema n = 12 and press n = 6) and one-way
ANOVA with unequal variances (Welch) test with a
twofold change cutoff was applied to determine which
genes showed significantly altered expression levels. If
more than a half of the data points in an experimental
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group had a “not detected” value - which corresponded
to a not significant data point (not significantly above
the background) - were excluded. Gene expression ra-
tios with p value of < 0.05 and log2 ratio of < −1 or log2
ratio of >1 (2 fold change) were considered as repres-
sion or overexpression respectively in gene activity. The
MIAME formatted microarray data are deposited to
EMBL - European Bioinformatics Institute ArrayEx-
press system [http://www.ebi.ac.uk/microarray-as/ae/]
with the Accession Number: E-MTAB-3678.
Quantitative real-time PCR (QRT-PCR)
In order to validate gene expression changes obtained
by DNA microarray, QRT-PCR was performed on an
Exicycler-96 instrument (Bioneer) with gene-specific
TaqMan assays and TaqMan protocol to monitor gene
expression. 1 μg of total RNA was reverse transcribed
using the High-Capacity cDNA Archive Kit (Life Tech-
nologies) according to the manufacturer’s instructions
in a final volume of 30 μL. After dilution with 60 μL of
water, 1 μL of the diluted reaction mix was used as
template in the QRT-PCR with FastStart TaqMan Probe
Master mix (Roche Applied Science) with the following
protocol: 10 min at 95 °C followed by 55 cycles of 95 °C
for 10 s and 60 °C for 30 s. The fluorescence intensity
of FAM dye was detected after each amplification step.
Relative expression ratios were calculated as normalized
ratios to rat GAPDH housekeeping gene. The final rela-
tive gene expression ratios were calculated as delta-
delta Ct values. Fold change refers to 2-ΔΔCt (in the case
of up-regulated genes) and – (1/2-ΔΔCt) (in the case of
down-regulated genes).
Immunohistochemistry
Cortical sections were prepared as described above for
electrophysiology at 320–500 μm thickness and immersed
immediately in a fixative containing 1 % paraformaldehyde
and 0.2 % (w/v) picric acid dissolved in 0.1 M phosphate
buffer (pH 7.3–7.4) for 4 h. Slices were resectioned at
50 μm thickness and a proteolytic antigen retrieval
method was used to localise membrane–bound epitopes.
Briefly, the tissue sections were incubated at 37 °C for
10 min in 0.1 M phosphate buffer followed by 5 min in
0.2 M HCl containing preheated 0.2 mg/ml pepsin (Dako),
then sections were washed in 0.1 M phosphate buffer for
2 × 10 and 1 × 30 min. For the comparison of KCNN4 ex-
pression in human control and cerebral edema cortex sec-
tions were kept in the same vial to ensure equal
conditions throughout the procedure. Following several
washes in tris-buffered saline, non-specific binding was
blocked by incubating sections in 20 % dried milk and
0.05 % Tween 20 for 2 h at room temperature. The tissue
sections were incubated with Rabbit-KCNN4 1:300
(Alomone, APC-064) or Rabbit-KCNN4 1:100 (Thermo
PA5-33875) primary antibody diluted in tris-buffered
saline, 2 days at 4 °C. After several washes with TBS,
sections were incubated in Alexa 488 -donkey anti-rabbit
(Jackson) diluted 1∶500, for 2 h at room temperature.
Sections were washed 3 times in tris-buffered saline and
then in 0.1 M phosphate buffer and mounted in
Vectashield mounting medium (Vector Laboratories,
Burlingame, CA).
Statistics
Data are given as mean ± S.D., datasets were statistically
compared using one-way ANOVA or Kruskal-Wallis test
and Wilcoxon test was used for pharmacological experi-
ments with SPSS software (IBM), differences were ac-
cepted as significant if p ≤ 0.05.
Results
In order to detect genes potentially regulated by edema
and increased ICP relative to control conditions, we per-
formed DNA microarray analysis in homogenized tissue
samples of the gray matter derived from the three
groups of patients (n = 9, 12 and 6 from Control, Edema
and Pressure groups, respectively). This preliminary ana-
lysis indicated 525 and 148 upregulated and 1119 and
168 downregulated genes in the edemic and ICP groups,
respectively (one way Welch ANOVA, p < 0.05, see
uploaded data). Based on these suspected changes and
potential clinical relevance, we selected 17 genes from
the Control versus Edema groups and 10 genes from the
Control versus Pressure group comparison for quantita-
tive real-time PCR (QRT-PCR) validation (Table 1).
QRT-PCR data were in agreement with microarray pre-
dictions in 12 (67 %) and 4 (40 %) cases in samples taken
from the Edema and Pressure groups, respectively.
The remainder of the tissue blocks used for microarray
analysis and QRT-PCR validation was cut for acute brain
slice preparations (with n = 2, 12 and 6 additional slice
experiments in Control, Edema and Pressure groups, re-
spectively) in order to record human pyramidal cells and
fast spiking interneurons in layer 2/3 using the whole
cell patch clamp mode. Differential interference contrast
microscopy was used to select putative pyramidal cells
and interneurons based on perisomatic morphology, and
the identity of pyramidal cells and interneurons was first
confirmed according to their regular spiking and fast
spiking firing characteristics in response to depolarizing
current pulses, respectively (Fig. 1). Analysis of basic
electrophysiological properties revealed that pyramidal
cells in the Edema (n = 148) and Pressure (n = 125)
groups had more depolarized resting membrane poten-
tials compared to the Control (n = 55) group (−80.4 ±
5.3, −81.2 ± 5.6 and −83.3 ± 6.6 mV, respectively, p <
0.03) and had higher input resistances and more depo-
larized action potential threshold potentials in the
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Edema group (72.9 ± 39.3 MΩ and −46.7 ± 6.3 mV)
compared to the Control and Pressure groups (47.7 ±
18.8 and 53.2 ± 33.4 MΩ, −50.9 ± 5.8–48.9 ± 5.8 mV, re-
spectively, p < 0.001). Fast spiking interneurons were re-
corded only in the Control (n = 27) and Edema (n = 47)
groups and were more depolarized at rest in edema
(−74.9 ± 4.8 vs. −68.9 ± 5.7 mV, p < 0.001). Interneurons
had higher input resistances and similar action potential
threshold potentials in the Edema group (140.7 ± 46.2
MΩ and −44.3 ± 7.1 mV) compared to the Control
group (127.7 ± 17.2 MΩ, p < 0.001 and −46.2 ± 5.1 mV,
respectively). In addition, we observed a decrease in the
frequency of spontaneous EPSPs arriving to human pyr-
amidal and fast spiking cells in the Edema (0.51 ± 0.39
and 5.96 ± 3.79 Hz, respectively) and to pyramidal cells
in the Pressure (0.50 ± 0.28 Hz) groups relative to the
Control group (1.51 ± 0.82 and 10.01 ± 3.19 Hz, p < 0.03
and p < 0.001, respectively) without a change in spon-
taneous EPSP amplitudes (pyramidal cells, 0.66 ± 0.40,
0.61 ± 0.30, 0.79 ± 0.37 mV; interneurons, 2.45 ± 0.67,
2.31 ± 0.71, respectively, Fig. 1.).
Post hoc anatomical recovery and analysis of dendritic
and axonal arborizations further ensured the identity of
pyramidal cells and classified interneurons as basket
cells based on axonal terminals frequently observed ad-
jacent to unlabeled somata (Fig. 1). To test potential
morphological alterations in pathological conditions, we
first compared the length of apical and basal dendrites
and the length of axons remaining in the slices based on
three-dimensional reconstructions human pyramidal
Table 1 Comparison of microarray and QPCR measurements on homogenates of cortical gray matter derived from the Control
versus Edema and Control versus Pressure groups of patients
Gene symbol Microarray QPCR
Log2 change
([odema] vs [cont])
p value (OneWay
Welch ANOVA)
Fold
change
Regulation Log2 change
(ΔΔCt [odema] vs [cont])
p value
(Student’s ttest)
Fold
change
Regulation
Control versus Edema
AQP1 1.71 0.0383 3.26 up 5.20 0.0000 36.85 up
AQP3 2.28 0.0007 4.87 up 3.02 0.0005 8.11 up
CACNA1B −1.06 0.0282 −2.09 down −2.71 0.0025 −6.55 down
CRH −2.82 0.0000 −7.06 down −3.59 0.0046 −12.00 down
DRD5 −1.17 0.0037 −2.26 down −3.32 0.0045 −9.98 down
GABRA4 −2.12 0.0091 −4.36 down 1.02 0.1008 2.03 up
GNRH1 −0.35 0.0629 −1.28 nc −2.14 0.0309 −4.42 down
GRIA3 −1.34 0.0132 −2.53 down −2.59 0.0058 −6.03 down
GRID1 −1.12 0.0230 −2.17 down 0.42 0.6465 1.34 nc
HMOX1 1.68 0.0013 3.21 up 2.57 0.0035 5.93 up
KCNN4 1.58 0.0002 2.99 up 1.63 0.0434 3.09 up
KCTD12 1.06 0.0025 2.09 up 0.34 0.6573 1.27 nc
NEUROD6 −2.37 0.0020 −5.17 down −0.16 0.8805 0.89 nc
NPY1R −1.61 0.0122 −3.06 down −1.55 0.0069 −2.93 down
SCN3B 1.33 0.0235 2.52 up 2.07 0.0057 4.20 up
SOD2 1.01 0.0030 2.02 up 3.33 0.0014 10.06 up
Control versus Pressure
AQP1 0.13 0.0383 1.09 nc 4.78 0.0015 27.38 up
GRIK4 0.18 0.0237 1.13 nc −2.44 0.0144 −5.41 down
HTR5A 1.20 0.0178 2.29 up 1.44 0.0221 2.71 up
KCNAB3 0.90 0.0008 1.86 up 1.52 0.0279 2.87 up
KCNS1 1.09 0.0200 2.14 up 3.05 0.0006 8.25 up
KCNS3 1.09 0.0024 2.13 up 0.77 0.5766 1.71 nc
PVALB 1.16 0.0011 2.24 up 2.02 0.0056 4.04 up
SLC2A3 −0.37 0.0231 −1.30 nc −1.21 0.0267 −2.31 down
SLC2A9 −0.22 0.4318 −1.16 nc −2.01 0.0056 −4.02 down
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cells recorded in the Control (n = 5; 3845 ± 2123, 3829 ±
1840, 17201 ± 9563 μm, respectively), Edema (n = 10;
3987 ± 1157, 4817 ± 1854, 16780 ± 7272 μm, respectively)
and Pressure (n = 5; 4528 ± 1384, 4861 ± 1591, 1629 ±
3985 μm, respectively) groups, however, we detected no
significant differences (p ≥ 0.12). Dendritic spines are dy-
namically altered in response to functional changes [4],
but are remarkably stable in adulthood [2]. Earlier exper-
iments found that the density of dendritic spines differs
between frontal and parietal areas in primates [11] and
developmentally stabilizes in adulthood around the aver-
age age of patients involved in our study in humans [32].
When measuring the density of spines on dendritic
branches of basal and oblique dendrites at distances
between 70 and 150 μm from the soma in samples
taken from the prefrontal gyrus, we found that spine
densities on dendrites of human pyramidal neurons
in the Edema (n = 38, 0.38 ± 0.18/μm) and Pressure
(n = 30, 0.43 ± 0.17/μm) groups were smaller of what
we found on pyramidal cells of the Control (n = 31,
0.55 ± 0.23/μm, respectively, p < 0.028) group (Fig. 1).
Spines receive the majority of glutamatergic input ar-
riving to pyramidal neurons and the drop in spine
densities indicate a loss of excitatory synapses in dis-
ease and, in turn, lower synapse numbers might con-
tribute to higher input resistances measured in
edema. The morphology of individual dendrites and
length of the dendritic arborization of basket cells in
the Control (n = 3, 4155 ± 804 μm) and Edema group
(n = 3, 4497 ± 741 μm) appeared similar, axonal
lenghts were not measured due to a high number of
thick branches cut at the surface of slices.
Fig. 1 Electrophysiological and morphological characteristics of human neurons analysed by single cell digital PCR. Somatodendritic (red) and
axonal (black) arborization of layer 2/3 pyramidal cells recorded in brain slices prepared from the Control (a), Edema (b) and Pressure (c) groups
of patients. Insets display voltage responses of the cells to hyperpolarizing and depolarizing current pulses with characteristic regular spiking
firing patterns (top) and representative periods of spontaneous subthreshold activity. Light microscopic image of the perisomatic region of a layer
2/3 human pyramidal cell recovered following electrophysiological recordings and cytoplasm harvests (d, top). Measurements of the density of
dendritic spines uncovered a significant drop in the Edema and Pressure groups relative to Control (bottom). Morphology and firing of human
fast spiking interneurons cells used for single cell digital PCR (e). Somatodendritic (blue) and axonal (black) arborization of layer 2/3 fast spiking
cells recorded in brain slices prepared from the Control (left) and Edema (right) groups of patients. Insets show voltage responses of the cells to
hyperpolarizing and depolarizing current pulses with characteristic fast spiking firing patterns (top) and representative periods of spontaneous
subthreshold activity
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Following electrophysiological characterization, we col-
lected cytoplasm samples from the recorded pyramidal
cells to verify mRNA expression changes detected homog-
enized tissue samples. Aiming for a precision of single
mRNA molecules in quantification, we performed single
cell reverse transcription and digital PCR on cytoplasm
samples aspirated into the recording pipette adapting our
method developed for rat neurons [13, 23]. We selected
12 genes for testing mRNA copy numbers in single pyr-
amidal neurons (n = 88) and fast spiking interneurons
(n = 31), using three to six cells for each gene compar-
ing Control versus Edema or Pressure groups of pa-
tients (Fig. 2). Copy numbers of the selected genes were
normalized to those of the homeostatic glyceraldehyde-
3-phoshate dehydrogenase GAPDH gene determined in
the same cells. As expected, GAPDH was expressed in
similar copy numbers in individual neurons across
Control, Edema and Pressure goups in pyramidal cells
(54 ± 13, 53 ± 15 and 57 ± 14, respectively) and in inter-
neurons of Control (55 ± 8) and Edema (51 ± 9) groups.
Human pyramidal cells showed significant mRNA copy
number changes in agreement with data from homoge-
nized tissue in 11 out of 12 genes. Single neuron digital
PCR validated changes were detected in genes coding cyto-
protective enzymes (HMOX1, SOD2) voltage-gated ion
channels (CACNA1B, KCNN4, KCNS1, SCN3B), aquapo-
rins (AQP1, AQP3), serotonin receptor 5A (HTR5A) and
corticotrophin releasing hormone (CRH). Moreover, par-
valbumin (PVALB), known to be expressed in GABAergic
interneurons but not in pyramidal cells, could not be de-
tected in copy numbers above noise level in human pyram-
idal cells in the Control and Pressure groups of patients,
while fast spiking cells expressed PVALB in copy numbers
of 12 ± 4 in the Control group (Fig. 2). The same primer
set detected up-regulation of the PVALB gene in homoge-
nized cortical samples in response to pressure suggesting
cell type specific expression in nonpyramidal cells. In con-
trast to pyramidal cells, genes tested in fast spiking inter-
neurons did not follow expression patterns predicted by
results of homogenized tissue. Genes showing significant
changes in tissue homogenates and pyramidal cells (AQP1,
HMOX1) were unchanged in mRNA copy numbers in fast
spiking cells collected from the Control or Edema groups
of patients. In addition, KCNN4 could not be detected
above signal threshold in fast spiking cells in these patient
groups. Thus, pyramidal cells and fast spiking interneurons
showed similar copy numbers of homeostatic genes, how-
ever, some cytoprotective enzymes (HMOX1), aquaporins
(AQP1) and voltage-gated ion channels (KCNN4) were dif-
ferently expressed by pyramidal cells and fast spiking inter-
neurons of control patients. Moreover, the expression of
HMOX1, AQP1 and KCNN4 was altered in pyramidal cells
but remained unchanged in fast spiking cells in response
to edema suggesting cell type specific regulation in patho-
logical conditions. Our single cell dataset limited to a sub-
set of neuron types does not exclude the contribution of
glia and endothel to tissue level changes or potential cell
type specific alterations in non-neuronal cell types in
Edema or Pressure groups of patients.
To functionally validate some results showing changes
in mRNA copy numbers in identified pyramidal cells, we
have chosen KCNN4 encoding the α-subunit of KCa3.1
channels. This follows earlier experiments in rat brain
edema models suggesting neuroprotective effects of Kcnn4
blockers [20], presumably acting on Kcnn4 channels lo-
cated on activated microglia [17] and immune-competent
Fig. 2 Results of single cell digital PCR performed on previously patch clamp recorded human pyramidal cells (pyr) and fast spiking interneurons
(int). Groups of patients are colour coded, asterisks indicate significant (p < 0.05) differences
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cells invading the brain [38]. The expression of Kcnn4 is
well established on non-neuronal cells of the brain [17, 38],
however, the presence of Kcnn4 channels in CNS neurons
has only been recently demonstrated in rat Purkinje cells
[12] and the expression or activity of Kcnn4 in neurons of
the human CNS has not been documented. Thus, we
tested the function of Kcnn4 on human pyramidal and fast
spiking cells in slices cut from the Control and Edema
groups first by introducing the small- and intermediate-
conductance calcium activated potassium channel activator
NS309 (500 nM) followed by the application of TRAM34
(1 μM), an inhibitor of intermediate-conductance calcium
activated potassium channels (Fig. 3). The kinetics of ac-
tion potentials and EPSPs of pyramidal cells (n = 10 from
three patients) in the Control group was not changed by
these pharmacological manipulations (0.616 ± 0.130 ms vs
0.608 ± 0.145 ms and 13.14 ± 2.05 ms vs 13.11 ± 2.10 ms,
Wilcoxon test p = 0.284 and 0.937, respectively), however,
the half-width of action potentials and EPSPs of human
pyramidal cells (n = 12 from three patients) recorded in the
Edema group was significantly altered by the same proced-
ure (from 0.584 ± 0.174 ms to 0.681 ± 0.209 ms and from
13.43 ± 2.40 ms to 15.76 from 0.584 ± 0.174 ms to 0.681 ±
0.209 ms 2.42 ms, Wilcoxon test p < 0.005 and 0.006, re-
spectively). Such alterations in action potential (0.334 ±
0.066 vs. 0.341 ± 0.071 ms) or EPSP (7.51 ± 2.47 vs. 7.54 ±
2.56 ms) half widths were not observed when testing fast
spiking interneurons (n = 9) in the Edema group in agree-
ment with single digital PCR results showing no expression
of KCNN4 in interneurons. Moreover, we tested the pres-
ence of Kcnn4 as a protein with immunocytochemistry
using antibodies against Kcnn4 performed simultaneously
on samples of the Control (n = 3) and Edema (n = 3)
groups (Fig. 3). This resulted in no detectable signal in pyr-
amidal cells of the Control group and moderate Kcnn4
positivity in pyramidal-like cells of the Edema group, how-
ever this was accompanied by strongly Kcnn4 immuno-
positive small, presumably glial cells and the identity of
which could not be verified due to suboptimal technical
possibilities associated with the human tissue and anti-
gen retrieval methods.
Discussion
The workflow presented above paves the way for detecting
neuron type specific changes at molecular, electrophysio-
logical and morphological level in various pathological
conditions in the human brain. Cell type specific therapy
targeted against key molecular components might form
the basis in future treatment of psychiatric or neurological
disorders [15, 19]. Emerging differences between the hu-
man cerebral cortex and its animal models widely used in
experimentation [24, 43] might contribute to factors lead-
ing to failing clinical trials in the field [15] and argue for
the use of human samples. In spite of recent treatment tar-
gets for cerebral edema and ICP including the Na+-K+-2Cl−
co-transporter (NKCC1) and the SUR1-regulated NCCa-ATP
(SUR1/TRPM4) channel [44], osmotherapy remains typic-
ally administered [36, 44]. Some of the edema/ICP modu-
lated and single human pyramidal cell verified gene
products identified here might be considered as novel
pharmacological targets in cell type specific neuroprotec-
tion. For example, aquaporins were suggested to be crucial
Fig. 3 Functional validation of KCNN4 mRNA copy number changes in detected human pyramidal cells. Waveforms of action potentials evoked
by depolarizing current injections (a) and of extracellularly evoked EPSPs (b) responded differently to the serial application of the small- and
intermediate-conductance calcium activated potassium channel activator NS309 (500 nM) and TRAM34 (1 μM), an inhibitor of intermediate-
conductance calcium activated potassium channels. The descending phase of action potentials and EPSPs was shortened in pyramidal cells
recorded in brain slices prepared from the Edema group, but remained unchanged in pyramidal neurons of the Control group and in fast spiking
interneurons of the Edema group. Traces shown are population averages. Confocal images of immunoreactions with antibodies against Kcnn4
performed simultaneously on samples of the Control and Edema groups showing a cross section of the gray matter (c) and part of layer 3 similar
to areas where electrophysiological experiments were performed (d). Pyramidal cells were not labeled in the Control group and moderate Kcnn4
positivity was detected in pyramidal cells (p) of the Edema group. In addition, intense immunolabeling for Kcnn4 was detected in glial cells
resembling astrocytes and interlaminar glia in both groups of patients
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in extracellular space- and osmoregulation in the brain
[18, 26] and are reportedly expressed in astrocytes
(AQP4 and AQP9) [10, 29] and in the epithelium of the
choroid plexus (AQP1) [30], but neuronal aquaporin
expression is not clear. In agreement with earlier re-
ports [10, 18, 29, 30], we detected no expression of
aquaporins in pyramidal cells of the Control group,
however, human pyramidal cells contained AQP1 and
AQP3 mRNA in edema and AQP1 in patients with in-
creased ICP, suggesting a redistribution of water (AQP1)
and water plus glycerin permeable (AQP3) aquaporins in
the cerebral cortex in response to disease. Furthermore,
human glia-derived brain tumors (gliomas, glioblastomas,
meningiomas and schwannomas) do not express AQP3
[31] arguing for a potentially neuron specific expression.
It remains to be elucidated whether potentially inter-
neuron selective expression of AQP1 in the Control group
contributes to neuron type selective water homeostasis.
Differential sensitivity of different neuronal and glial pop-
ulations in various types of head injury is well docu-
mented [7, 37] and cell type specific analysis under these
conditions might identify underlying pathomechanisms
leading to prevention or treatment.
Pharmacological and immunohistochemical results
confirm our single cell digital PCR data and suggest a
functionally detectable presence of KCNN4 and KCa3.1
channels in edema relative to control conditions in hu-
man pyramidal cells, however, these channels are absent
in fast spiking interneurons in both groups of patients.
Moreover, our results support earlier findings function-
ally linking KCNN4 and edema [20] and raise the possi-
bility that the functional expression of Kcnn4 changes
from purely glial to glial and neuronal in control and
edemic conditions, respectively. A potential neuropro-
tective function of Kcnn4 channels on human pyramidal
cells in edema might be the contribution to the suppres-
sion of EPSP summation and to the curtailment of action
potentials leading to lower Ca2+ entry and excitotoxicity
[12]. Speculatively, this effect of Kcnn4 might counteract
Ca2+ influx due to large amplitude EPSPs resulting from
the increased input resistance and rising from a more
depolarized resting membrane potential in edema. The
cell type dependent absence of this mechanism suggests
differential survival of neuron populations in edema mak-
ing fast spiking interneurons especially vulnerable when
responding to extremely powerful unitary EPSPs driving
these cells to fire in human microcircuits [24]. In addition,
voltage-gated Ca2+ channels, like Cav2.2 conducting N-
type Ca2+ currents encoded by the CACNA1B gene found
here to be down-regulated in human pyramidal cells in
edema, are essential in action potential to release coupling
at presynaptic terminals [6, 40] and could effectively sup-
press excitatory output and counteract excitotoxicity. In-
deed, blockade of N-type VGCCs decrease neuronal
damage associated with ischemic brain injury in animal
models [42] and the CACNA1B gene is associated with
cerebral infarction in a human population [45]. The
voltage-gated Na+-channel β3 subunit encoding gene
SNC3B found to be up-regulated in human pyramidal
cells in edema might also be involved mechanisms govern-
ing excitability. Studies in Scn3b−/− mice revealed spon-
taneous cardiac arrhythmia and conduction abnormalities
[14] and the recently uncovered structure of trimeric β3
subunits of Na+-channels together with their suggested in-
teractions with α subunits [27] predict future testing of β
subunit dependent μ-conotoxin sensitivity of Na+-chan-
nels [47] in disease or treatment. Pyramidal neuron pro-
tective regulation of KCNN4, CACNA1B, and SCN3B
suggested here could be effectively boosted by other cyto-
protective processes involving heme oxygenase 1 [16] and
mitochondrial superoxide dismutase 2 encoded by the
HMOX1 and SOD2 genes which are up-regulated in pyr-
amidal neurons in edema. The voltage-gated K+-channel α
subunit Kv9.1 encoded by the KCNS1 gene up-regulated
in human pyramidal cells in the Pressure group has been
found to be associated with multiple chronic pain states
[9], however, interpretation of our findings is difficult
knowing that electrically silent Kv9.1 subunits are not cap-
able of forming functional homo-multimeric channels
[39] but can suppress currents mediated by Kv2 and Kv3
α subunit families [3].
Conclusions
We applied the combination of cellular electrophysi-
ology, anatomy and single cell digital PCR to human
neurons identified in brain slices in situ to assess mRNA
expression and corresponding functional changes in re-
sponse to edema and increased intracranial pressure. In
material derived from patients with edema, mRNA copy
numbers of AQP1, AQP3, HMOX1, KCNN4, SCN3B
and SOD2 increased, while CACNA1B, CRH decreased
in individual pyramidal cells, however, AQP1, HMOX1-
and KCNN4 remained unchanged in single cell digital
PCR performed on fast spiking cells. In single pyramidal
cells derived from patients with increased intracranial
pressure, the copy number of AQP1, HTR5A and
KCNS1 mRNAs was increased. Pharmacological and im-
munohistochemical results also suggested the presence
of KCNN4 encoding the α-subunit of KCa3.1 channels
in edema on pyramidal cells, but not on interneurons
validating single cell digital PCR data. The frequency of
spontaneous EPSPs decreased on pyramidal cells in both
pathophysiological conditions and on fast spiking inter-
neurons in edema. This was parallelled by an increase in
input resistances on both cell types and by a drop in
dendritic spine density on pyramidal cells consistent
with a loss of excitatory synapses. The anatomical and/
or physiological changes in individually identified human
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pyramidal and fast spiking cells in edema and increased
intracranial pressure reveal cell type specific quantitative
changes in gene expression and some of the modulated
gene products identified here might be considered as
novel pharmacological targets in cell type specific
neuroprotection.
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